DFP-10917 in Combination With Venetoclax in Relapsed or Refractory Acute Myeloid Leukemia

NCT06382168 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

RECRUITING

Status

39

Enrollment

INDUSTRY

Sponsor class

Conditions

Leukemia, Myeloid, Acute

Interventions

DRUG: DFP-10917
DRUG: Venetoclax

Sponsor

Delta-Fly Pharma, Inc.